Anzeige
Mehr »
Mittwoch, 08.10.2025 - Börsentäglich über 12.000 News
Defence-Aktie mit Ritterschlag: Regierungs-Einladung zur größten Militärmesse
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0B7QK | ISIN: GB0034330679 | Ticker-Symbol: DWV
Frankfurt
08.10.25 | 08:03
0,031 Euro
0,00 % 0,000
Branche
Dienstleistungen
Aktienmarkt
Sonstige
1-Jahres-Chart
ANGLE PLC Chart 1 Jahr
5-Tage-Chart
ANGLE PLC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0040,04811:33

Aktuelle News zur ANGLE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08:02Angle PLC Announces Strategy Update80Appointment of Executive Chairman, proposed change of name and strategy updateCompany to pursue revised strategy and name change to CelLBxHealth plcDr. Jan Groen, the current Non-Executive Chairman...
► Artikel lesen
29.09.Angle PLC Announces Presentation of Data on Glioblastoma153CLINICAL study SHOWS DETECTION OF CTCs in glioblastoma PatientsGBM CTC isolation only possible with Parsortix label-free methodologyData presented at the 7th ACTC meeting GUILDFORD, SURREY / ACCESS...
► Artikel lesen
ANGLE Aktie jetzt für 0€ handeln
29.09.Angle: Presentation of Data on Glioblastoma-
12.09.IN BRIEF: Angle CEO and finance lead step down after shareholder talks1
12.09.Angle founder and CEO steps down after shareholder backlash1
12.09.Angle CEO and finance director resign2
12.09.Angle PLC Announces Board Changes266GUILDFORD, SURREY / ACCESS Newswire / September 12, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in...
► Artikel lesen
09.09.Shares in Angle tumble on gloomy outlook2
09.09.Angle H1 Pre-tax Loss Widens, Lowers FY25 Guidance; Stock Down5
09.09.Angle shares suffer as interim loss widens amid weaker revenue3
09.09.Angle PLC Announces Change of Adviser137APPOINTMENT OF NOMINATED ADVISER AND SOLE BROKER GUILDFORD, SURREY / ACCESS Newswire / September 9, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating...
► Artikel lesen
09.09.Angle PLC Announces Interim Results175ANGLE plc("ANGLE" or "the Company")Interim Results for the six months ended 30 June 2025COMMERCIALISATION PROGRESSED ACROSS MULTIPLE FRONTS DESPITE REVENUE PRESSURE FROM ADVERSE MARKET CONDITIONSLarge...
► Artikel lesen
05.09.Angle PLC Announces Notice of Results233ANGLE plc ("the Company") Notice of Interim Results and Webcast GUILDFORD, SURREY / ACCESS Newswire / September 5, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with...
► Artikel lesen
05.09.ANGLE plc legt Halbjahresergebnisse am 9. September vor2
05.09.LONDON - ANGLE plc to release interim results on September 92
20.08.Angle teams up with Myriad Genetics on cancer patient blood testing1
20.08.ANGLE plc partners with Myriad Genetics to advance cancer diagnostics2
20.08.ANGLE plc: ANGLE Announces Collaboration with Myriad Genetics216Assessment of feasibility for use of Parsortix derived circulating tumour cell (CTC) DNA with Myriad Genetics' existing tissue-based diagnostic test GUILDFORD, SURREY / ACCESS Newswire / August 20,...
► Artikel lesen
08.07.Studie mit Parsortix-System von ANGLE deckt genetische Vielfalt in Tumor-Clustern als Metastasen-Treiber auf1
08.07.Angle PLC Announces Parsortix Enables Study Of Cancer Progression709New publication in Nature Genetics using Parsortix identifies CTC clusters as promising targets to stop the spread of cancer GUILDFORD, SURREY / ACCESS Newswire / July 8, 2025 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY)...
► Artikel lesen
Weiter >>
54 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1